A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
Clinical trial NCT00050843 · COMPLETED
Trial details
- NCT number
- NCT00050843
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.